Brief Advice, Nicotine Replacement Therapy Sampling and Active Referral (BANSAR) for Smoking Fathers
NCT ID: NCT03671707
Last Updated: 2021-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1053 participants
INTERVENTIONAL
2018-10-10
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoking Cessation for Fathers of Sick Children
NCT07014124
A Video-led Smoking Cessation Intervention in Helping Male Smokers Whose Partners Got Pregnant to Quit Smoking
NCT03236025
Factors Related to the Intention to Quit Among Male Smokers During Their Wives Pregnancy
NCT03401021
Deliver an Evidence-based Smoking Cessation Intervention for Smokers Attending A&E Departments in Hong Kong
NCT03818360
Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking
NCT05474651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Given the busy clinical settings in Hong Kong Public Hospitals, evidence-based, low-cost and sustainable brief cessation intervention applicable in real-world practice is imperative. Informed by previous research, a combined cessation intervention of brief advice, nicotine replacement therapy sampling and active referral (BANSAR) has been developed for smoking expectant father. This multicentre, pragmatic, assessor-blinded, individually-randomized controlled trial aims to evaluate BANSAR for smoking cessation outcomes in smoking expectant father visiting prenatal clinics in Hong Kong
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Brief AWARD advice + Nicotine replacement therapy sampling + Active referral
Brief AWARD advice
Subject will receive brief, face-to-face counselling following a structured AWARD model at baseline :
1. Ask: smokers will be asked about their smoking behaviour
2. Warn about the harms of smoking using a leaflet which contain information about harms of secondhand smoke to women, fetus and infant, motivational messages to quit and smoking cessation services.
3. Advise to quit or reduce their smoking and use the provided 1-week nicotine replace therapy sample as soon as possible
4. Refer smokers to smoking cessation services if they agree.
5. Do-it-again: repeat the AWARD advise through telephone boosters at 2-week and 4-week after baseline
Nicotine replacement therapy sampling
Subjects will receive 1-week supply of free nicotine patch or gum with dosage based on participants' number of cigarette per day. An information card containing reminders of nicotine replacement therapy use and actions to handle potential side effects will be provided.
Active referral
Subjects will be encouraged to select and access a smoking cessation services in Hong Kong. If the subjects agree, their contact information will be sent to the smoking cessation service providers for further arrangement.
Control group
Very brief advice (VBA) + Leaflet
Very brief advice
Subjects will receive general advice to quit
Leaflet
Subjects will receive a standard leaflet on perinatal smoking by Department of Health
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief AWARD advice
Subject will receive brief, face-to-face counselling following a structured AWARD model at baseline :
1. Ask: smokers will be asked about their smoking behaviour
2. Warn about the harms of smoking using a leaflet which contain information about harms of secondhand smoke to women, fetus and infant, motivational messages to quit and smoking cessation services.
3. Advise to quit or reduce their smoking and use the provided 1-week nicotine replace therapy sample as soon as possible
4. Refer smokers to smoking cessation services if they agree.
5. Do-it-again: repeat the AWARD advise through telephone boosters at 2-week and 4-week after baseline
Nicotine replacement therapy sampling
Subjects will receive 1-week supply of free nicotine patch or gum with dosage based on participants' number of cigarette per day. An information card containing reminders of nicotine replacement therapy use and actions to handle potential side effects will be provided.
Active referral
Subjects will be encouraged to select and access a smoking cessation services in Hong Kong. If the subjects agree, their contact information will be sent to the smoking cessation service providers for further arrangement.
Very brief advice
Subjects will receive general advice to quit
Leaflet
Subjects will receive a standard leaflet on perinatal smoking by Department of Health
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to read and communicate in Chinese
3. Living together in the past 7 days
1. Having smoked 1 or more cigarettes daily in the past 3 months
2. Having a telephone or mobile phone contact
1\. Not having smoked any cigarette in the past 30 days
Exclusion Criteria
2. Having psychiatric/psychological diseases or regular psychotropic medications
3. Having used smoking cessation aids or participated in other smoking cessation services or projects in the past 3 months
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Food and Health Bureau, Hong Kong
OTHER_GOV
Queen Mary Hospital, Hong Kong
OTHER
Pamela Youde Nethersole Eastern Hospital
OTHER
Kwong Wah Hospital
OTHER
Queen Elizabeth Hospital, Hong Kong
OTHER
United Christian Hospital
OTHER
Princess Margaret Hospital, Hong Kong
OTHER_GOV
Tuen Mun Hospital
OTHER_GOV
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Wang Man-Ping
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Man Ping Wang, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Nursing, The University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Luk TT, Lam TH, Leung WC, Leung KY, Cheung KW, Kwa C, Siong KH, Tang KK, Lee KW, Hsieh CJ, Wu YS, Li WH, Wang MP. Brief Advice, Nicotine Replacement Therapy Sampling, and Active Referral for Expectant Fathers Who Smoke Cigarettes: A Randomized Clinical Trial. JAMA Intern Med. 2021 Aug 1;181(8):1081-1089. doi: 10.1001/jamainternmed.2021.2757.
Luk TT, Hsieh CJ, Leung WC, Leung KY, Cheung KW, Kwa C, Siong KH, Tang KK, Lee KW, Li WH, Lam TH, Wang MP. Brief cessation advice, nicotine replacement therapy sampling and active referral (BANSAR) for smoking expectant fathers: Study protocol for a multicentre, pragmatic randomised controlled trial. Contemp Clin Trials. 2020 Jun;93:106006. doi: 10.1016/j.cct.2020.106006. Epub 2020 Apr 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKUCTR-2422
Identifier Type: REGISTRY
Identifier Source: secondary_id
15162691
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.